Intravenous Immunoglobulin G Modulates Peripheral Blood Th17 and Foxp3+ Regulatory T Cells in Pregnant Women with Recurrent Pregnancy Loss
Version of Record online: 19 MAR 2014
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
American Journal of Reproductive Immunology
Volume 71, Issue 5, pages 441–450, May 2014
How to Cite
Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3+ regulatory T cells in pregnant women with recurrent pregnancy loss. Am J Reprod Immunol 2014; 71: 441–450, , , , , , .
- Issue online: 16 APR 2014
- Version of Record online: 19 MAR 2014
- Manuscript Accepted: 5 JAN 2014
- Manuscript Received: 20 NOV 2013
- Korean Health Technology R&D Project
- Ministry of Health & Welfare, Republic of Korea. Grant Number: A120136
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.